These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 17899571

  • 21. Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial.
    Paternoster DM, Tudor L, Milani M, Maggino T, Ambrosini A.
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):198-201. PubMed ID: 15280147
    [Abstract] [Full Text] [Related]

  • 22. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L.
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [Abstract] [Full Text] [Related]

  • 23. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA, DiGiovanni L, Jones TN, Marshalla M, Mastrogiannis D, Della Torre M.
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [Abstract] [Full Text] [Related]

  • 24. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
    Romero R, Conde-Agudelo A, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Nicolaides KH.
    Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
    [Abstract] [Full Text] [Related]

  • 25. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?
    Ovalle A, Romero R, Gómez R, Martínez MA, Nien JK, Ferrand P, Aspillaga C, Figueroa J.
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):453-64. PubMed ID: 16966109
    [Abstract] [Full Text] [Related]

  • 26. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial.
    Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M.
    Am J Obstet Gynecol; 2006 Mar; 194(3):617-23. PubMed ID: 16522388
    [Abstract] [Full Text] [Related]

  • 27. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ, Nguyen LK, Pham TD, He YTN, Vu KN, Phan MTN, Le TQ, Le CH, Vuong LN, Mol BW.
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [Abstract] [Full Text] [Related]

  • 28. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.
    Brizot ML, Hernandez W, Liao AW, Bittar RE, Francisco RPV, Krebs VLJ, Zugaib M.
    Am J Obstet Gynecol; 2015 Jul; 213(1):82.e1-82.e9. PubMed ID: 25731690
    [Abstract] [Full Text] [Related]

  • 29. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B, Karolinski A, Ocampo MC, Laterra C, Hösli I, Fernández D, Surbek D, Huespe M, Drack G, Bunader A, Rouillier S, López de Degani G, Seidenstein E, Prentl E, Antón J, Krähenmann F, Nowacki D, Poncelas M, Nassif JC, Papera R, Tuma C, Espoile R, Tiberio O, Breccia G, Messina A, Peker B, Schinner E, Mol BW, Kanterewicz L, Wainer V, Boulvain M, Othenin-Girard V, Bertolino MV, Irion O, 4P trial group.
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [Abstract] [Full Text] [Related]

  • 30. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A, Romero R.
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [Abstract] [Full Text] [Related]

  • 31. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis.
    Conde-Agudelo A, Romero R, Rehal A, Brizot ML, Serra V, Da Fonseca E, Cetingoz E, Syngelaki A, Perales A, Hassan SS, Nicolaides KH.
    Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.
    Cabrera-García L, Cruz-Melguizo S, Ruiz-Antorán B, Torres F, Velasco A, Martínez-Payo C, Avendaño-Solá C, PESAPRO trial Group.
    Trials; 2015 Sep 25; 16():427. PubMed ID: 26407852
    [Abstract] [Full Text] [Related]

  • 33. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.
    Majhi P, Bagga R, Kalra J, Sharma M.
    J Obstet Gynaecol; 2009 Aug 25; 29(6):493-8. PubMed ID: 19697195
    [Abstract] [Full Text] [Related]

  • 34. Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix.
    McKay LA, Holford TR, Bracken MB.
    Ultrasound Obstet Gynecol; 2014 May 25; 43(5):596-7. PubMed ID: 24585456
    [No Abstract] [Full Text] [Related]

  • 35. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial.
    Borna S, Sahabi N.
    Aust N Z J Obstet Gynaecol; 2008 Feb 25; 48(1):58-63. PubMed ID: 18275573
    [Abstract] [Full Text] [Related]

  • 36. Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial.
    Dugoff L, Berghella V, Sehdev H, Mackeen AD, Goetzl L, Ludmir J.
    Ultrasound Obstet Gynecol; 2018 May 25; 51(5):573-579. PubMed ID: 28940481
    [Abstract] [Full Text] [Related]

  • 37. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial.
    Saccone G, Maruotti GM, Giudicepietro A, Martinelli P, Italian Preterm Birth Prevention (IPP) Working Group.
    JAMA; 2017 Dec 19; 318(23):2317-2324. PubMed ID: 29260226
    [Abstract] [Full Text] [Related]

  • 38. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J, OPPTIMUM study group.
    Lancet; 2016 May 21; 387(10033):2106-2116. PubMed ID: 26921136
    [Abstract] [Full Text] [Related]

  • 39. [Progesterone for Prevention of Preterm Birth--Evidence-based Indications].
    Kuon RJ, Abele H, Berger R, Garnier Y, Maul H, Schleußner E, Rath W, Experts for the Prediction and Prevention of Preterm Birth (X4PB) – www.x4pb.de.
    Z Geburtshilfe Neonatol; 2015 Jun 21; 219(3):125-35. PubMed ID: 26114408
    [Abstract] [Full Text] [Related]

  • 40. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.
    El-Refaie W, Abdelhafez MS, Badawy A.
    Arch Gynecol Obstet; 2016 Jan 21; 293(1):61-67. PubMed ID: 26044148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.